Interstitial Lung Disease
📧 Sign up to get email alerts when something new happens for Interstitial Lung Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-05Clinical Trial Results: Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease [Phase 2]
Phase 2 clinical trial results on optimizing and standardizing 129Xe gas exchange MRI to visualize regional therapy response in interstitial…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Aerobic Exercise in Patients With Pulmonary Hypertension [Phase 2]
Phase 2 clinical trial update on aerobic exercise in patients with pulmonary hypertension (including interstitial lung disease) has complete…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) [Phase 2, Phase 3]
Extension study update for Treprostinil Palmitil Inhalation Powder (TPIP) in pulmonary hypertension associated with interstitial lung diseas…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis [Phase 3]
A Phase 3 trial evaluating inhaled treprostinil for idiopathic pulmonary fibrosis and interstitial lung disease has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease [Phase 3]
This is a Phase 3 extension study of inhaled treprostinil for fibrotic lung diseases, sponsored by United Therapeutics, with enrollment by i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Hiatal Hernia and Pulmonary Involvement
A University of Virginia-sponsored clinical trial evaluating hiatal hernia with pulmonary involvement, including interstitial lung disease, …
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: A Study to Evaluate Long-term Safety of Nintedanib in Children and Adolescents With Interstitial Lung Disease (InPedILD®-ON) [Phase 3]
A Phase 3 study evaluating the long-term safety of nintedanib in children and adolescents with interstitial lung disease has completed and r…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Diagnostic Yield and Safety of Lung Biopsy Techniques in Interstitial Lung Diseases [NA]
A completed clinical trial evaluates the diagnostic yield and safety of different lung biopsy techniques for interstitial lung diseases, led…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: A Study of Mosliciguat in PH-ILD [Phase 2]
Phase 2 study evaluating mosliciguat in patients with pulmonary hypertension associated with interstitial lung disease; current status is ac…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Post-marketing Surveillance of Ofev Capsules in Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype in Japan
A post-marketing surveillance study of Ofev (nintedanib) in Japanese patients with chronic fibrosing interstitial lung diseases with a progr…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: A Study of the Pharmacokinetics and Safety of Single-dose Inhaled RJ026 in Healthy Volunteers and Patients With Interstitial Lung Disease [Phase 1]
This Phase 1 study examines the pharmacokinetics and safety of a single-dose inhaled RJ026 in healthy volunteers and patients with interstit…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: 129Xe MRI Cardiopulmonary [Phase 2]
Phase 2 clinical trial update for a 129Xe MRI cardiopulmonary study; the trial investigates interstitial lung disease and related cardiopulm…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Recognition of Early Pulmonary Structural Changes by Using Real-time High Fidelity Expiratory CO2 Analysis [NA]
A completed clinical trial evaluating real-time high-fidelity expiratory CO2 analysis to detect early pulmonary structural changes in COPD a…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs) [Phase 3]
Phase 3 trial evaluating BI 1015550 for progressive fibrosing interstitial lung diseases has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Evaluation of Efficacy and Safety of Rituximab With Mycophenolate Mofetil in Patients With Interstitial Lung Diseases [Phase 3]
ClinicalTrials.gov update on a Phase 3 study evaluating rituximab in combination with mycophenolate mofetil for interstitial lung diseases. …
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Clinical Relevance of Thoracic Echography for the Early Diagnosis of Interstitial Lung Disease in Systemic Scleroderma - Pilot Study [NA]
A completed pilot study evaluating whether thoracic echography can aid early diagnosis of interstitial lung disease in systemic sclerosis. T…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Exercise Performance on Ambient Air vs. Low-Flow Oxygen Therapy With Chronic Lung Diseases [NA]
A clinical trial comparing exercise performance on ambient air versus low-flow oxygen therapy in people with chronic lung diseases has compl…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Hydroxychloroquine (HCQ) in Pediatric Interstitial Lung Disease (ILD) [Phase 2]
A Phase 2 study of hydroxychloroquine in children with interstitial lung disease was terminated, and the results have been posted (as of 202…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension [Phase 2]
A Phase 2 trial evaluating treprostinil for interstitial lung disease-associated pulmonary hypertension has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: MOBoxy: MoblO2 to Maintain Oxygenation [NA]
This clinical trial update describes a study of MOBoxy (MoblO2) intended to maintain oxygenation in patients with COPD and interstitial lung…
-
CLINICAL_TRIALS trial_result · 2025-10-28Clinical Trial Update: INCHANGE - Nintedanib for Changes in Cough and Dyspnea in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation
A real-world, completed evaluation of nintedanib for changes in cough and dyspnea in patients with chronic fibrosing interstitial lung disea…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis [Phase 2]
Phase 2 clinical trial evaluating autologous stem cell transplantation in systemic sclerosis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Prognostic Score Comparison in IPF and HP
A completed clinical trial compares prognostic scoring methods in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis (interstiti…
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: Impact of Lung Boost Device on Ventilatory Functions and Fatigue in Patients With Interstitial Lung Diseases [NA]
This clinical trial update reports on the impact of a Lung Boost device on ventilatory function and fatigue in patients with interstitial lu…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Tolerability and Safety of Nintedanib in Myositis Associated Interstitial Lung Disease [NA]
This clinical trial update describes tolerability and safety data for nintedanib in patients with myositis-associated interstitial lung dise…